Sign Up to like & get
recommendations!
1
Published in 2022 at "EBioMedicine"
DOI: 10.1016/j.ebiom.2021.103761
Abstract: Background Heterologous COVID-19 vaccination regimens combining vector- and mRNA-based vaccines are already administered, but data on solicited adverse reactions, immunological responses and elicited protection are limited. Methods To evaluate the reactogenicity and humoral as well…
read more here.
Keywords:
chadox1 ncov;
boost;
sars cov;
vaccination ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "iScience"
DOI: 10.1016/j.isci.2021.103694
Abstract: Heterologous SARS-CoV-2 vaccine approaches with a second mRNA-based vaccine have been favored in the recommendations of many countries over homologous vector-based ChAdOx1 nCoV-19 vaccination after reports of thromboembolic events and lower efficacy of this regimen.…
read more here.
Keywords:
chadox1 ncov;
bnt162b2;
sars cov;
vaccination ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Annals of Laboratory Medicine"
DOI: 10.3343/alm.2023.43.3.290
Abstract: While numerous studies have evaluated humoral responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines, data on the cellular responses to these vaccines remain sparse. We evaluated T cell responses to ChAdOx1-nCoV-19 and BNT162b2…
read more here.
Keywords:
bnt162b2 vaccinations;
chadox1 ncov;
ncov bnt162b2;
bnt162b2 ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Vaccines"
DOI: 10.3390/vaccines10030392
Abstract: The efficacy of one dose Ad5-nCoV has been concerning. This study aimed to evaluate the effect of a single dose BNT162b2 in individuals after a completed Ad5-nCoV vaccination regiment compared to a group without this…
read more here.
Keywords:
bnt162b2;
sars cov;
ad5 ncov;
igg antibodies ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Vaccines"
DOI: 10.3390/vaccines9080857
Abstract: Despite limited data on safety and immunogenicity, heterologous prime-boost vaccination is currently recommended for individuals with ChAdOx1 nCoV-19 prime immunization in certain age groups. In this prospective, single-center study we included 166 health care workers…
read more here.
Keywords:
vaccination;
chadox1 ncov;
ncov bnt162b2;
heterologous chadox1 ... See more keywords